Atomic Invest’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.5K Buy
409
+34
+9% +$2.15K ﹤0.01% 214
2026
Q2
$22K Sell
375
-69
-16% -$3.96K ﹤0.01% 195
2026
Q1
$26.5K Buy
444
+136
+44% +$7.93K 0.01% 160
2025
Q4
$16.7K Buy
+308
New +$14.8K 0.01% 164

Other funds holding BMY

Atomic Invest's BMY Position: Q3 2026 in Review

Atomic Invest increased its Bristol-Myers Squibb (BMY) stake by 9.1% in Q3 2026, buying an estimated $2.15K and bringing the position to 409 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #214.

Atomic Invest first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. The position peaked at $26.5K in Q1 2026. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Atomic Invest held 409 shares of Bristol-Myers Squibb worth $25.5K as of Q3 2026.
  • Atomic Invest bought 34 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.15K.
  • Bristol-Myers Squibb made up ﹤0.01% of Atomic Invest's portfolio in Q3 2026, its #214 holding.
  • Atomic Invest first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • Atomic Invest's Bristol-Myers Squibb position peaked at $26.5K in Q1 2026.
  • 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Atomic Invest's 13F filing for Q3 2026, filed 13 Nov 2026.